Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
Tag: Phase
UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting
- Phase II data demonstrate that rozanolixizumab was well tolerated by patients with primary ITP across all dose groups - Clinically relevant improvements in platelet count ...
Lees verder
Hovione Announces Successful End-of-phase 2 Meeting With the FDA and Outlines Phase 3 Program for Minocycline Topical Gel
CORK, Ireland, Sept. 20, 2019 /PRNewswire/ -- Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the ...
Lees verder
Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study
LEIDEN, Netherlands, June 11, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") today announces that, following receipt of the Dutch investigating ...
Lees verder
Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Repor
Not intended for U.S. media -- 48-week results provide additional evidence of relapse reduction for investigational evobrutinib -- Evobrutinib demonstrated ...
Lees verder
Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of
Not intended for US, Canada and UK-based media DARMSTADT, Germany and NEW YORK, Feb. 16, 2019 /PRNewswire/ -- -- JAVELIN Renal 101 shows significant improvement in ...
Lees verder
Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park
LONDON, August 3, 2018 /PRNewswire/ -- Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet ...
Lees verder
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile
TAIPEI, Taiwan, July 26, 2018 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today that it has successfully completed a Phase 1 multiple ...
Lees verder
ENDOSCOPY Publishes the MORA Phase III Trial for PLENVU® (NER1006), the Only 1 Litre Peg Based Bowel Preparation[i]
AMSTERDAM, July 19, 2018 /PRNewswire/ -- Norgine B.V. today announced that results from the PLENVU(R) Phase III MORA trial were published in ENDOSCOPY, a monthly peer-reviewed ...
Lees verder
McLaren Launches the Next Phase of its Pioneering esports Programme
LONDON, July 9, 2018 /PRNewswire/ -- The most open and inclusive racing esports tournament on the planet - global participation, multiple platforms, the biggest games. Twelve ...
Lees verder
Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published
TOKYO, June 29, 2018 /PRNewswire/ -- Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 ...
Lees verderNieuwe berichten
Persbericht: Nieuwe CEO voor Curvature
Curvature, een specialist in onafhankelijke IT-ondersteuning, producten en services,heeft een... Lees verder →
Persbericht: Valid bouwt datawarehouse met meetdata in Azure
Eindhoven, 29 augustus 2019 – Om goed te kunnen werken... Lees verder →
Persbericht: Sharp ontvangt ISO 27001-certificaat voor databeveiliging
Utrecht, 29 augustus 2019 – Sharp, leverancier van onderscheiden print-,... Lees verder →
